Drug-coated balloons for infrapopliteal disease: digging deep to understand the impact of a negative trial

Affiliations

¹ Division of Cardiovascular Medicine and the Vascular Center, University of California, Davis Medical Center, Sacramento, California. Electronic address: john.laird@ucdmc.ucdavis.edu.
² Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.

Free article

Editorial

John R Laird et al. J Am Coll Cardiol. 2014.

Free article

. 2014 Oct 14;64(15):1577-9.

doi: 10.1016/j.jacc.2014.07.960.

¹ Division of Cardiovascular Medicine and the Vascular Center, University of California, Davis Medical Center, Sacramento, California. Electronic address: john.laird@ucdmc.ucdavis.edu.
² Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.

No abstract available

Keywords: amputation; angioplasty; balloon; critical limb ischemia; diabetes mellitus; limb salvage; paclitaxel; peripheral vascular disease.

Comment on

Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M, Snead DB, Kent KC, Rocha-Singh KJ; IN.PACT DEEP Trial Investigators. Zeller T, et al. J Am Coll Cardiol. 2014 Oct 14;64(15):1568-76. doi: 10.1016/j.jacc.2014.06.1198. J Am Coll Cardiol. 2014. PMID: 25301459 Clinical Trial.